Lipid metabolizing enzyme ACSM2B is a potential negative regulator of liver cancer progression.

Asian J Surg

Department of General Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China; The Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital, Wenzhou Medical University, Zhoushan, Zhejiang Province, China. Electronic address:

Published: May 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.asjsur.2024.01.077DOI Listing

Publication Analysis

Top Keywords

lipid metabolizing
4
metabolizing enzyme
4
enzyme acsm2b
4
acsm2b potential
4
potential negative
4
negative regulator
4
regulator liver
4
liver cancer
4
cancer progression
4
lipid
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!